RCT of bumetanide in hypokalaemic periodic paralysis (HypoPP) using abductor digiti minimi compound muscle action potential (CMAP) as an objective outcome measure
Scalco, R.S., Morrow, J., Manole, A., Skorupinska, I., Bellin, A., Ricciardi, F., Matthews, E., Hanna, M.G., Fialho, D.Volume:
28
Language:
english
Journal:
Neuromuscular Disorders
DOI:
10.1016/s0960-8966(18)30370-5
Date:
April, 2018
File:
PDF, 30 KB
english, 2018